Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Club Indigo- An Education India’s Initiative for Revolutionary Transformation in School Students” Business
  • Discover the Magic of Friendship and Farewell in That’s Why Dogs Fly by Radhika Malhotra Lifestyle
  • ‘IIFL JITO Ahimsa Run’ aims to unite Indians and mark its entry into world record books Business
  • Shankaracharya Swami Sadanand Saraswati Visits Dr. Abhishek Verma, Blesses Family and ShivSena Leadership Lifestyle
  • Fandawm Launches A Music Label With The Release Of The Romantic Single Kamaal Kare Tu Entertainment
  • Lupin AptivateAchchiBhook School Foodie Quiz 2022: India’s largest food quiz concluded with a thumping success Press Release
  • Jaipur Sets a Unique World Record: 220+ Joint Replacement Patients Perform Tadasana Together Lifestyle
  • Ovum Hospitals, Bangalore’s #1 Women & Child Hospital, launches a state-of-the-art IVF & Infertility Centre in Bangalore Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • Dr. Pooja Nadkarni Singh: A Renowned Obstetrics and Gynaecology Expert in India Health
  • Monkeypox: Understanding the Global Health Emergency Health
  • MagicTouch Brazil Approval: A Turning Point for Cardiovascular Innovation Health
  • Kindness Practice Foundation conducted free cancer awareness camp at Mumbai Health
  • Sakhiya Skin Clinic Introduces Apollo Duet for Advanced Skin Rejuvenation Health
  • Landmark TRIC Valve Implantation at Dana Shivam Heart & Superspeciality Hospital, Jaipur by Dr Sunil Garssa Health

Recent Posts

  • MGM Maran: Orchestrating Global Growth for the MGM Group with Recent China Visit
  • Zero NPA. Zero Shortcuts. Zero Compromise. The Best of 96 Years
  • The Quiet Glamour of Hayaam by Zam Zam Perfumers
  • PSS Legal Appoints Rakhi Kapoor As its Chief Wellness Officer, Marking A First For India’s Corporate Legal Sector
  • A Pharmaceutical Injectable Manufacturing Company, opens its IPO on 21st May, 2026.

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Shree Interior Wudtech, Revolutionizing the Modular Furniture Industry in Navi Mumbai Business
  • Raj Gharana Metals Launches Aarti Machine and Brass Pooja Set in Celebration of Navratri Business
  • Brixline revolutionises India’s construction & home ownership market Business
  • Making A New Wave In The Musical Scene With Endless Love Is CLOSER Singer And Song-Writer JoaQimein Martin! Entertainment
  • Launch of Odisha Craft Odyssey – Celebrating the Heritage and Innovation of Odisha’s Craft Traditions Lifestyle
  • IUS Digital Solution, Empowering AI-Powered Marketing for Businesses of All Sizes Business
  • HDFC Bank Celebrates Republic Day in a Unique Way in Surat, Vadodara, and Ahmedabad National
  • Monu Patel- An evolution to emerging hope for society’s welfare Lifestyle

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme